PortfoliosLab logoPortfoliosLab logo
ISIN
US4055521003
IPO Date
Jul 22, 2022

Highlights

Market Cap
$39.07B
Enterprise Value
$47.18B
EPS (TTM)
$0.62
PE Ratio
14.13
PEG Ratio
2.19
Total Revenue (TTM)
$19.27B
Gross Profit (TTM)
$12.29B
EBITDA (TTM)
$4.76B
Year Range
$8.65 - $11.28
Target Price
$10.20
ROA (TTM)
8.54%
ROE (TTM)
16.96%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

HLN Performance Chart

Haleon plc (HLN) is down 12.6% since the beginning of the year. At $9 per share, HLN is trading 22.7% below its 52-week high of $11.


Loading charts...

S&P 500 Index

Returns By Period

Haleon plc (HLN) has returned -12.61% so far this year and -19.56% over the past 12 months.


Haleon plc

1D
0.23%
1M
-5.63%
YTD
-12.61%
6M
-7.09%
1Y
-19.56%
3Y*
3.50%
5Y*
10Y*

Benchmark (S&P 500 Index)

1D
-0.74%
1M
4.90%
YTD
10.35%
6M
10.28%
1Y
26.52%
3Y*
20.83%
5Y*
12.30%
10Y*
13.66%
*Multi-year figures are annualized to reflect compound growth (CAGR)

HLN Monthly Returns History

Based on dividend-adjusted daily data since Jul 22, 2022, HLN's average daily return is +0.03%, while the average monthly return is +0.68%. At this rate, an investment would double in approximately 8.5 years.

Historically, 54% of months were positive and 46% were negative. The best month was Dec 2022 with a return of +16.1%, while the worst month was Aug 2022 at -14.9%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 4 months.

On a daily basis, HLN closed higher 50% of trading days. The best single day was Dec 6, 2022 with a return of +7.7%, while the worst single day was Aug 10, 2022 at -8.4%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20263.56%5.73%-9.58%-6.47%-1.95%-3.75%-12.61%
2025-0.73%7.50%1.08%-0.23%11.82%-8.63%-9.06%4.55%-8.47%3.34%5.50%3.37%7.84%
2024-0.36%4.39%0.43%0.47%-1.06%-2.13%10.77%11.84%3.93%-8.41%-0.31%-1.24%17.99%
20231.25%-2.72%4.07%8.97%-9.36%4.23%5.13%-6.18%1.34%-2.88%5.81%-3.86%4.21%
2022-5.13%-14.94%1.84%0.49%12.58%16.11%7.96%

Benchmark Metrics

Haleon plc has an annualized alpha of 3.60%, beta of 0.28, and R2 of 0.04 versus S&P 500 Index. Calculated based on daily prices since July 25, 2022.

  • This stock participated in 34.82% of S&P 500 Index downside but only 27.94% of its upside - more exposed to losses than it benefited from rallies.
  • Beta of 0.28 may look defensive, but with R2 of 0.04 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R2 of 0.04 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
3.60%
Beta
0.28
0.04
Upside Capture
27.94%
Downside Capture
34.82%

Return for Risk

Risk / Return Rank

HLN ranks 7 for risk / return — in the bottom 7% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


HLN Risk / Return Rank: 77
Overall Rank
HLN Sharpe Ratio Rank: 66
Sharpe Ratio Rank
HLN Sortino Ratio Rank: 88
Sortino Ratio Rank
HLN Omega Ratio Rank: 1010
Omega Ratio Rank
HLN Calmar Ratio Rank: 66
Calmar Ratio Rank
HLN Martin Ratio Rank: 55
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Haleon plc (HLN) and compare them to S&P 500 Index.


HLNBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.93

2.24

-3.18

Sortino ratio

Return per unit of downside risk

-1.27

3.07

-4.35

Omega ratio

Gain probability vs. loss probability

0.86

1.41

-0.55

Calmar ratio

Return relative to maximum drawdown

-0.90

2.93

-3.83

Martin ratio

Return relative to average drawdown

-1.55

13.52

-15.07

Dividends

Dividend History

Haleon plc provided a 2.17% dividend yield over the last twelve months, with an annual payout of $0.19 per share. The company has been increasing its dividends for 2 consecutive years.


1.30%1.40%1.50%1.60%1.70%$0.00$0.05$0.10$0.15202320242025
Dividends
Dividend Yield
PeriodTTM202520242023
Dividend$0.19$0.18$0.16$0.10

Dividend yield

2.17%1.73%1.65%1.26%

Monthly Dividends

The table displays the monthly dividend distributions for Haleon plc. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.00$0.00$0.13$0.00$0.00$0.13
2025$0.00$0.00$0.00$0.12$0.00$0.00$0.00$0.06$0.00$0.00$0.00$0.00$0.18
2024$0.00$0.00$0.11$0.00$0.00$0.00$0.00$0.05$0.00$0.00$0.00$0.00$0.16
2023$0.06$0.00$0.00$0.00$0.00$0.05$0.00$0.00$0.00$0.00$0.10

Dividend Yield & Payout


Dividend Yield

Haleon plc has a dividend yield of 2.17%, which is quite average when compared to the overall market.

Payout Ratio

Haleon plc has a payout ratio of 22.44%, which is below the market average. This means Haleon plc returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Haleon plc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Haleon plc was 24.83%, occurring on Sep 2, 2022. Recovery took 65 trading sessions.

The current Haleon plc drawdown is 22.09%.


Related event

Drawdown

Fall

Recovery

Underwater

Bear market2022
-24.83%Sep 2022
24d3mo 5d
3mo 29dAug 2022 - Dec 2022
2025 bear market2025
-23.11%Sep 2025
3mo 24d
1y 1dJun 2025 - now
2025 correction2025
-15.72%Jan 2025
3mo 14d3mo 18d
7mo 2dOct 2024 - May 2025
2023 correction2023
-13.08%Oct 2023
6mo 9d8mo 19d
1y 2moApr 2023 - Jul 2024
2023 pullback2023
-8.10%Mar 2023
20d10d
1moFeb 2023 - Mar 2023

Drawdown Indicators


HLNBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-24.83%

-56.78%

+31.95%

Max Drawdown (1Y)

Largest decline over 1 year

-21.78%

-9.10%

-12.68%

Max Drawdown (3Y)

Largest decline over 3 years

-23.11%

-18.90%

-4.21%

Max Drawdown (5Y)

Largest decline over 5 years

-25.43%

Max Drawdown (10Y)

Largest decline over 10 years

-33.92%

Current Drawdown

Current decline from peak

-22.09%

-0.74%

-21.35%

Average Drawdown

Average peak-to-trough decline

-8.37%

-10.72%

+2.35%

Ulcer Index

Depth and duration of drawdowns from previous peaks

12.66%

1.97%

+10.69%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Haleon plc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Haleon plc is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for HLN, comparing it with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, HLN has a P/E ratio of 14.1. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for HLN compared to other companies in the Drug Manufacturers - Specialty & Generic industry. HLN currently has a PEG ratio of 2.2. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for HLN relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, HLN has a P/S ratio of 2.0. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for HLN in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, HLN has a P/B value of 2.4. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with HLN

Add Haleon plc to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with HLN